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Abstract
Introduction: The Work Productivity and Activity Impairment (WPAI) questionnaire is a well validated instrument to
measure impairments in work and activities. However, its validation among patients with rheumatoid arthritis (RA)
has not been well established. The present study’s purpose is to evaluate the construct validity of the WPAI-general
health version among RA patients and its ability to differentiate between RA patients with varying health status.
Methods: Patients who were enrolled in the Early Rheumatoid Arthritis Network cohort and were employed at
their most recent follow-up were recruited into this sub-study. A questionnaire battery incorporating the WPAI was
administered along with a number of health outcomes including the Multidimensional Health Assessment
Questionnaire, fatigue and patient assessment of disease activity. The construct validity of the WPAI was tested by
the correlations between the WPAI and the health outcomes and other measures of productivity. Student’s t tests
were used to identify whether the WPAI outcomes differed between the two levels of heath status based on the
median of health outcomes.
Results: A total of 150 patients completed the WPAI questionnaire. The average age was 52 years old and the
disease duration was 37.5 months since the first rheumatology visit. Of the 137 patients who were working for pay,
26 reported missing work in the past week due to their health problem, accounting for 45.5% of their working
time (absenteeism). While 123 patients were working, 24% of their work was impaired due to their health problem
(presenteeism). In addition, 33% of the patients’ regular daily activities (activity impairment) had been prevented
due to their health problems. There were moderate correlations between the WPAI absenteeism and function,
pain, fatigue, and disease severity (r = 0.34 to 0.39). The WPAI presenteeism and activity impairment were strongly
correlated with the health outcomes (0.67 to 0.77). Patients with more severe disease status (for example, low/high
functional disability by median) had significantly higher absenteeism (4%/15%), presenteeism (15%/39%), and
activity impairment (19%/53%) than those with less severe disease status.
Conclusions: The WPAI is a valid questionnaire for assessing impairments in paid work and activities in RA patients
and for measuring the relative differences between RA patients with different health status.
Introduction
Rheumatoid arthritis (RA) is the most common form of
inflammatory arthritis with a prevalence rate of about 1%
and an annual incidence of 3 per 10,000 adults [1]. There
is considerable evidence that RA can impact patients’
productivity even during the very early phase of the dis-
ease. According to Burton et al., the time between RA
onset until 50% probability of being permanently work
disabled varied from 4.5 to 22 years [2]. Merkesdal et al.
found that within the first three years of RA, there was
an average of 82 days of sick leave per person-year and
26% of patients lost work because of RA [3]. Sick leave
was more significant in the first year with an average of
113 days. In a study on patients with inflammatory joint
conditions present for <12 months, Geuskens et al.
found that 26% of all patients and 35% of the patients
with RA reported more than two weeks of sick leave in
the past six months [4]. In terms of the impact of RA on
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unpaid work, a recent clinical trial showed that at base-
line patients with RA reported 9.2 missed days of house-
hold work and 11.2 days with productivity less than or
equal to 50% in household work in one month [5].
Another trial at baseline found that RA patients got
about 11 hours of unpaid or paid help to take over their
unpaid work [6]. In the literature, functional disability
has consistently been found to be associated with work
disability [7-9]. In addition, pain and poor physical func-
tioning were also associated with increased sick leave and
reduced productivity at work [4,10].
In general, the impact of RA on paid work includes
employed people missing time from work (absenteeism),
reduced performance while at work (presenteeism),
reduced routine working hours through changing or even
losing jobs (employment status change). The impact on
unpaid work usually refers to the impact of health pro-
blems on regular daily activities such as household work,
shopping, and child care.
The Work Productivity and Activity Impairment
(WPAI) questionnaire is an instrument to measure
impairments in both paid work and unpaid work [11,12].
It measures absenteeism, presenteeism as well as the
impairments in unpaid activity because of health problem
during the past seven days. It has been validated to quan-
tify work impairments for numerous diseases such as
asthma, psoriasis, irritable bowel syndrome (IBS), anky-
losing spondylitis (AS) and Crohn’s disease [12-15].
In addition, the WPAI questionnaire has been used to
compare work impairments between treatment groups in
clinical (studies and) trials or between subjects with dif-
ferent disease severity levels [13-18]. However, the valida-
tion of this instrument among patients with RA has not
been well established.
The objective of the study is to evaluate the construct
validity of the WPAI-general health version (WPAI-GH)
among RA patients and its ability to differentiate
between RA patients with varying health status.
Materials and methods
Study design
This study is a cross-sectional study. Patients were
recruited from a UK based registry of RA, the Early
Rheumatoid Arthritis Network (ERAN), which is a group
of rheumatology centres in the UK and Eire with an
interest in treatment patterns and outcome in patients
with recently diagnosed RA in normal clinical settings.
Patients had already consented to take part in the ERAN
research study. Patients who reported they were
employed at their most recent follow-up with ERAN
were invited to participate in this substudy. Those who
agreed were sent a questionnaire battery. The question-
naire battery including the WAPI-GH and health out-
come measures was administered at one time point. The
WPAI-GH was used to measure the patients’ work
impairments. Ethical approval was gained from West
Herts Multi-centre Research Ethics Committee, UK.
WPAI-GH outcomes
The WPAI-GH consists of six questions: 1 = currently
employed; 2 = hours missed due to health problems;
3 = hours missed other reasons; 4 = hours actually
worked; 5 = degree health affected productivity while
working (using a 0 to 10 Visual Analogue Scale (VAS));
6 = degree health affected productivity in regular unpaid
activities (VAS) [11,12]. The recall period for the ques-
tions 2 to 6 is seven days. Four main outcomes can be
generated from the WPAI-GH and expressed in percen-
tages by multiplying the following scores by 100: 1) per-
cent work time missed due to health = Q2/(Q2 + Q4)
for those who were currently employed; 2) percent
impairment while working due to health = Q5/10 for
those who were currently employed and actually worked
in the past seven days; 3) percent overall work impair-
ment due to health Q2/(Q2 + Q4) + ((1 - Q2/(Q2 +
Q4)) × (Q5/10)) for those who were currently employed;
4) percent activity impairment due to health Q6/10 for
all respondents [11,12]. For those who missed work and
did not actually work in the past seven days, the percent
overall work impairment due to health will be equal to
the percent work time missed due to health.
Construct validity: relation with health
We selected a number of instruments measuring health
status that we believed would be correlated with pro-
ductivity outcomes. The Multidimensional Health
Assessment Questionnaire (MDHAQ) is a validated
one-page questionnaire including a measure of func-
tional disability, pain, and patient global health estimate
[19]. The scoring of the MDHAQ was as follows: a)
Function score: 10 activities of daily living (ADL) were
scored 0 to 3, 0 = “without any difficulty”, 1 = “with
some difficulty”, 2 = “with much difficulty”, and 3 =
“unable to do.” To be consistent with the Health Assess-
ment Questionnaire score (HAQ), the sum of 10 ADL
scores was divided by 10 to give a score of 0 to 3; b)
Pain VAS; c) Patient global estimate VAS on health
impact. Fatigue VAS was used to measure patient
assessment of fatigue problem. Patient global assessment
(PtGA) of disease activity was used as a proxy of disease
activity. Previous studies have found a strong correlation
between the patient global assessment of disease activity
and the disease activity score including 28-joint counts,
with a VAS score greater than 40 indicating high disease
activities [20]. All the VAS scales were presented as 21
circles to facilitate scoring without a ruler and an arith-
metic scale of 0 to 10 in 0.5 unit increments was printed
below the circles.
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Construct validity; relation with other measure of
productivity
Questions on productivity adapted from alternative
questionnaires were also included to assess the consis-
tency of responses. They included the number of absent
workdays in the past three months, a question adapted
from the PROductivity and DISease Questionnaire
(PRODISQ) [21], and questions adapted from Health
and Labour Questionnaire (HLQ) [22,23] asking about
lost hours due to presenteeism (the difference between
the numbers of hours actually worked in the past seven
days and the estimated number of hours used to com-
plete the same work if patients did not experience any
health problems) and the impact of health on unpaid
work activities (hours of getting help with unpaid work
activities in the past seven days).
In addition, the ability of the WPAI-GH to discrimi-
nate between better and worse health states was tested
by dividing patients into two groups based on the med-
ian of the scores for function, pain, health impact, fati-
gue and disease activity (Better status: ≤median; Worse
status: >median).
Analysis
We measured the extent to which WPAI productivity out-
comes were correlated with health status outcomes and
the productivity questions adapted from alternative ques-
tionnaires. Due to the skewed nature of the productivity
outcome data, nonparametric correlation (Spearman’s cor-
relation coefficient) was used to assess construct validity.
For a comparison between two groups, the effect size,
the standardized mean difference between two groups on
a measured outcome, was calculated for all WPAI-GH
outcomes. An effect size of one indicates a change in
magnitude equivalent to one standard deviation. Accord-
ing to Cohen [24,25], the absolute value of effect sizes (d)
can be categorized as small (d = 0.2 to 0.5), medium (d =
0.5 to 0.8), or large (d > 0.8). A larger effect size indicates
better discriminative ability. Student t tests were used to
identify whether WPAI outcomes differed between the
two levels of heath status. Wilcoxon tests were also used
due to the skewed nature of the productivity outcome
data.
Results
A total of 354 patients believed to be in some sort of
work in ERAN were contacted for the study and 186
(53%) agreed to take part in the study and were sent
the questionnaires. One hundred and fifty-two patients
sent back the questionnaire but two of these patients
did not respond to the questions in the WPAI so that
no WPAI outcomes could be calculated. Therefore, a
total of 150 patients were included in the analysis.
Among the 150 patients, the average age was 52 years
old and 72% were female (Table 1). The sample’s dis-
ease duration was 37.5 months since their first rheuma-
tology visit. Patients had relatively mild function (0.6),
pain (3.6), fatigue (4.6) and disease activity (3.6). Of the
137 (91%) patients that were working for pay, 26 (19%)
reported missing work (absenteeism) in the past week
due to their health, accounting for 45.5% of their work-
ing time (Table 2). While 123 patients were working,
24% of their actual work was impaired due to their
health problem (presenteeism) with only 34 (28%)
patients reported no such loss. In addition, 33% of the
patients’ regular daily activities had been prevented due
to their health problems.
For the correlation analysis between the WPAI pro-
ductivity outcomes and the health status outcomes, all
the correlations were in the logical direction and were
highly significant (Table 3). There were moderate corre-
lations between percent work time missed due to health
and function, pain, fatigue, health impact, and disease
severity (0.34 to 0.39). The other three WPAI outcomes
were strongly correlated with all of the health status
outcomes (0.67 to 0.77).
The number of absent workdays in the past three
months was about 4.4 (standard deviation (SD): 10.5)
days. The number of hours lost due to presenteeism in
the past seven days was 1.4 (2.8) hours. Overall, patients
got 4.0 (8.3) hours of help with their unpaid work activ-
ities in the past seven days. The percent of work time
missed due to health was moderately correlated with
number of absent workdays in the past three months
(r = 0.56). The correlation between impairment while
working and hours lost due to presenteeism was 0.39
and that between activity impairment and hours of get-
ting help on unpaid work activities was 0.39.
When the patients were divided into two groups
according to the median of each health status outcome
Table 1 Demographics and health status
Variables (n = 150) Mean (SD) Median (Q1 to Q3)
Age 52.1 (10.0) 52.9 (45.6 to 60.0)
Duration since onset of
symptom (months)
48.7 (23.2) 46.0 (33.0 to 60.0)
Duration since first clinic
visit (months)
37.5 (18.3) 35.7 (23.7 to 50.9)
Function (0 to 3) 0.6 (0.5) 0.5 (0.2 to 0.9)
Pain (0 to 10) 3.6 (2.5) 3.0 (1.5 to 5.5)
Pt global estimate
(0 to 10)
3.0 (2.4) 2.5 (1.0 to 5.0)
Fatigue (0 to 10) 4.6 (2.9) 5.0 (2.0 to 7.0)
PtGA (0 to 10) 3.6 (2.6) 3.0 (1.5 to 5.5)
n %
Female 108 72.0
Pt global estimate, patient global estimate on health impact; PtGA, patient
global assessment of disease activity; Q1, first quartile; Q3, third quartile.
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variable, each of WPAI productivity outcomes was sig-
nificantly lower among patients with better health status
than patients with worse health status (Table 4). For
example, patients with low functional disability (lower
than median) had a significantly lower percentage of
work time missed due to health (4 vs. 15), lower percen-
tage of impairment while working due to health (15 vs.
39), and lower percentage of activity impairment due to
health (19 vs. 53) than those with high functional dis-
ability. According to the effect size, WPAI outcomes
had large discriminative abilities (1.10 to 1.79) except
the percent work time missed due to health which
showed a medium discriminative ability (0.43 to 0.63).
The test results from t tests and Wilcoxon tests agreed
(only the results of the t tests were reported).
Discussion
This is the first study to examine the construct validity
of the WPAI-GH in a relatively large sample of patients
with RA. The results support that the WPAI-GH dis-
plays construct validity as measured by moderate to
strong correlations with all health status measures in
terms of functional disability, pain, fatigue and disease
activity (Table 3). As such, it appears that the WPAI
productivity outcomes are assessing constructs that are
relevant and important to patients with RA. However,
the WPAI is moderately correlated with other produc-
tivity outcomes such as hours lost due to presenteeism
and hours of getting help on unpaid work activities
measured using the questions adapted from the HLQ.
This may suggest that it measures another aspect of pre-
senteeism and unpaid work productivity in comparison
with the HLQ. In addition, according to the effect size
analysis and paired test, the WPAI-GH could discrimi-
nate across health status with worse score being asso-
ciated with measures indicating worse health status
among the patients with RA. The results demonstrate
the validity of the WPAI-GH is consistent with previous
WPAI validation results for other diseases.
It is interesting that absenteeism (percent of work time
missed) correlates less with health than presenteeism
(impairment while working). This may be because the
decision to stay home depends on more contextual fac-
tors than impairments while working that are related to
the diseases; for example, the type of work, the fear to be
a burden to colleagues, attitude towards work, conse-
quence for income, fear to lose work, and so on. This
suggests that absenteeism measures another dimension
of the impact of the disease which is not measured by
other health outcome instruments. One previous item
response theory study in AS showed that work participa-
tion did not fit the unidimensionality of all other cate-
gories/domains of the International Classification of
Functioning, Disability and Health that refer to body
functions, body structures, activities and participation
[26]. There is also the role of the social security system
that is expected to influence more absenteeism than pre-
senteeism/activity impairment, which makes absenteeism
less comparable internationally [27]. However, the high
correlation between impairment while working/activity
Table 2 WPAI outcomes
Variables n Mean (SD) Median (Q1 to Q3)
Patients working for pay 137
Percent work time missed due to health 136 8.7 (25.2) 0 (0 to 0)
Percent work time missed due to health (those with missed time >0) 26 45.5 (41.2) 18 (12 to 100)
Patients who actually worked in the past seven days 123
Percent impairment while working due to health 122 24.0 (22.7) 20 (0 to 40)
Percent impairment while working due to health (those with % impairment while working >0) 88 33.3 (20.1) 30 (20 to 50)
Percent overall work impairment due to health 135 29.1 (29.8) 20 (0 to 46)
All patients 150
Percent activity impairment due to health 150 33.3 (27.6) 30 (10 to 60)
Percent activity impairment due to health (those with % activity impairment >0) 123 40.7 (25.1) 30 (20 to 60)
Q1, first quartile; Q3, third quartile.
Table 3 Spearman correlations between WPAI outcomes and health status outcomes
Function Pain Pt global estimate Fatigue PtGA
Percent work time missed 0.39 0.36 0.36 0.37 0.34
Percent impairment while working 0.69 0.75 0.74 0.67 0.76
Percent overall work impairment 0.67 0.73 0.71 0.68 0.73
Percent activity impairment 0.73 0.77 0.77 0.68 0.77
Pt global estimate, patient global estimate on health impact; PtGA, patient global assessment of disease activity.
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impairment and other health outcomes may be partially
attributable to the fact that they all use the same measur-
ing 0 to 10 scale.
Among health outcomes, pain and PtGA were more
correlated with work impairment and activity impair-
ment than function and fatigue. In the literature, pain
was found to be highly associated with reduced produc-
tivity at work [10]. However, no previous studies have
shown that disease activity is highly correlated with
work and activity impairment among people with RA.
Further studies are needed to confirm the relationships.
There are two aspects of productivity that are impor-
tant to measure: first, the work difficulties or work
impairments due to health which influence work related
quality of life and/or psychosocial impacts such as job
satisfaction and stress, and second, the actual productiv-
ity losses due to health. The WPAI was designed predo-
minantly to measure the first aspect but has been used in
the past to measure and value the productivity losses for
economic evaluations. However, the WPAI does not
necessarily capture sufficient information to comprehen-
sively measure actual productivity losses. To do so, it
requires measures of actual lost time estimators as well
as contextual factors such as job type, workplace team
dynamics and compensation mechanism (a manuscript
from Zhang et al. - in submission).
A total of 186 patients agreed to participate in the
study but 150 patients completed WPAI questions and
were included in our analysis. To identify whether there
were non-response biases, we compared patient charac-
teristics, including age, gender, duration since onset of
symptom, duration since fist clinic visit, as well as disease
activity score, HAQ and PtGA measured in the most
recent follow-up with ERAN, between the 150 patients
who were included in the analysis and the 36 patients
who were not. No significant differences were found.
A limitation of this study is that no independent
employment measure (gold standard) of missed work
hours or work impairment while working was used as a
validation criterion. Severens et al. investigated the
agreement between registered and reported sick leave
[28]. They demonstrated that 95% of the reported days
of sick leave matched registered data perfectly when the
recall period was limited to two and four weeks. This
percentage decreased to 87%, 57%, and 51% for 2, 6,
and 12 months, respectively. Reilly et al. assessed the
accuracy of self-reported work hours missed measured
by the WPAI:IBS version using retrospective diary
among patients with IBS [13]. The high convergence of
the WPAI:IBS and retrospective diary suggested that
self-reports of percentage work hours missed during the
past week were accurate.
In terms of work impairment while at work, presen-
teeism, Lerner et al. established the relationship between
their Work Limitation Questionnaire and objective work
productivity measures in two types of occupations [29].
However, it is quite difficult to measure the relationship
between self-reported and objective measures of produc-
tivity at work because the objective measures varied
with occupations as well as workplaces and so is the
relationship [30]. Zhang et al. have demonstrated that
the work productivity loss while at work varies widely
with the approach chosen among people with arthritis
[31,32]. Future research should focus on assessing the
relationship between self report and objective measures
of productivity loss and examining which approach pro-
vides more accurate measure of productivity loss.
We did not test the reliability of the WPAI-GH
among patients with RA in this study. The test-retest
reliability of the WPAI has been well established in
populations with different diseases [33,34]. We assumed
that this would not be different for the population with
Table 4 WPAI outcomes between two patient groups defined by the median for each health status outcome
Function Pain Pt global estimate Fatigue PtGA
Percent work time missed Better 4.2 (19.0)‡ 1.5 (7.2) 2.0 (7.7)† 3.9 (15.8)‡ 1.6 (7.1)
Worse 15.5 (31.5) 16.3 (34.0) 15.6 (33.9) 14.5 (32.4) 16.9 (34.6)
Effect size 0.46 0.61 0.55 0.43 0.63
Percent impairment while working Better 14.5 (18.8) 11.6 (15.0) 10.9 (13.1) 12.8 (16.8) 11.7 (14.3)
Worse 39.1 (20.1) 39.6 (21.1) 40.0 (21.7) 38.7 (21.0) 41.2 (21.0)
Effect size 1.27 1.56 1.66 1.38 1.69
Percent overall work impairment Better 17.6 (24.8) 12.2 (16.7) 11.8 (15.7) 14.8 (22.1) 12.3 (16.1)
Worse 46.5 (28.2) 47.4 (30.0) 47.2 (30.3) 46.0 (28.9) 48.9 (30.1)
Effect size 1.10 1.46 1.48 1.22 1.55
Percent activity impairment Better 19.0 (21.1) 15.7 (17.0) 15.1 (17.0) 19.6 (21.0) 17.5 (19.0)
Worse 52.7 (23.3) 51.9 (24.4) 52.0 (23.7) 49.9 (25.6) 51.9 (24.5)
Effect size 1.53 1.73 1.79 1.30 1.58
Pt global estimate, patient global estimate on health impact; PtGA, patient global assessment of disease activity.
If not indicated, t test P values <0.001; †, t test P values <0.01; ‡, t test P values <0.05.
Better status, ≤median; Worse status, >median. The median for each health status outcome was shown in Table 1.
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RA. The responsiveness of the WPAI-GH among
patients with RA will be tested in a future study.
This is not the first application of WPAI among RA
patients. One application of WPAI in RA was a study pub-
lished as an abstract at 2008 American College of Rheuma-
tology annual scientific meeting [35]. It was used to
explore the impact of health problems on presenteeism in
patients recently diagnosed with RA as compared to a
healthy comparison group. Another application of WPAI
was conducted by the Canadian Arthritis Network work
productivity study, which was to compare different presen-
teeism measures among people with arthritis [31,32]. How-
ever, in both studies, only the question measuring
impairment while working (question 5 of WPAI) was used
and the main purposes were not to validate the instrument.
The WPAI has been used to measure work productivity
in other diseases such as asthma, psoriasis, irritable bowel
syndrome (IBS), ankylosing spondylitis (AS) and Crohn’s
disease [13-18]. The mean percent work time missed has
been reported to be 5.0 for people with asthma [18], 4.4
for people with IBS [13], 9.0 for people with AS [14] and
18.3 for people with Crohn’s disease [15], respectively,
compared with 8.7 for people with RA in our study popu-
lation. The percent impairment while working has been
reported to be 20.0 in asthma, 15.5 in psoriasis [17], 32.4
in IBS, 41.7 in AS and 40.5 in Crohn’s disease compared
with 24.0 in RA from our study. Correspondingly, per-
cent activity impairment has been found to be 32.0, 23.7,
41.4, 54.9 and 52.0 compared with 33.3 in our study of
RA patients. According to these WPAI outcomes, it
shows that RA has a relatively moderate impact on work
productivity compared to other diseases. However, even
for a certain disease, the WPAI outcomes vary with dif-
ferent levels of severity. Given that our RA population
has early disease and therefore typically mild disease
severity, the other disease populations compared may
have a relatively more severe disease status. Simple com-
parisons should be made with caution.
Conclusions
Construct validity and the discriminative ability of the
WPAI-GH have been established in this study. Thus,
the WPAI-GH is a valid questionnaire for assessing
impairments in paid work and activities in RA patients
and for measuring the relative differences between RA
patients with different health status. The WPAI-GH is
useful for measuring productivity outcomes in clinical
practice. Further studies are needed to validate a tool
for valuing productivity loss in economic analyses.
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